Quarterly report · Q1

Period2024-01-01 → 2024-03-31
Filed2024-05-14
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 34
MetricValuePeriodScopeSource row
Revenue¥5.6bn2024-01-01 → 2024-03-31Cons.Net sales
Revenue¥20.4bn2023-01-01 → 2023-12-31Cons.Net sales (5-year summary)
Revenue¥4.9bn2023-01-01 → 2023-03-31Cons.Net sales
Operating income¥720m2024-01-01 → 2024-03-31Cons.Operating income
Operating income¥851m2023-01-01 → 2023-03-31Cons.Operating income
Ordinary income¥873m2024-01-01 → 2024-03-31Cons.Ordinary income
Ordinary income¥2.9bn2023-01-01 → 2023-12-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥961m2023-01-01 → 2023-03-31Cons.Ordinary income
Profit before tax¥848m2024-01-01 → 2024-03-31Cons.Income before income taxes
Profit before tax¥820m2023-01-01 → 2023-03-31Cons.Income before income taxes
Net income (owners)¥571m2024-01-01 → 2024-03-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥2.0bn2023-01-01 → 2023-12-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥511m2023-01-01 → 2023-03-31Cons.Profit loss attributable to owners of parent
Net income¥584m2024-01-01 → 2024-03-31Cons.Profit loss
Net income¥509m2023-01-01 → 2023-03-31Cons.Profit loss
Total assets¥29.8bnat 2024-03-31Cons.Assets
Total assets¥29.4bnat 2023-12-31Cons.Assets
Total assets¥26.7bnat 2023-03-31Cons.Total assets (5-year summary)
Total liabilities¥9.4bnat 2024-03-31Cons.Liabilities
Total liabilities¥8.8bnat 2023-12-31Cons.Liabilities
Net assets / equity¥20.4bnat 2024-03-31Cons.Net assets
Net assets / equity¥20.6bnat 2023-12-31Cons.Net assets
Net assets / equity¥19.5bnat 2023-03-31Cons.Net assets (5-year summary)
Cash and deposits¥9.5bnat 2024-03-31Cons.Cash and deposits
Cash and deposits¥9.4bnat 2023-12-31Cons.Cash and deposits
EPS (basic)¥8.12024-01-01 → 2024-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥27.762023-01-01 → 2023-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥7.242023-01-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥8.082024-01-01 → 2024-03-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥27.682023-01-01 → 2023-12-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥7.222023-01-01 → 2023-03-31Cons.Diluted earnings per share (5-year summary)
Equity ratio68.2%at 2024-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio69.6%at 2023-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio72.7%at 2023-03-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 42
SegmentItemPeriodValue
Otherother segmentsrevenue2024-01-01 → 2024-03-31¥299m
Otherother segmentsrevenue external2024-01-01 → 2024-03-31¥271m
Otherother segmentsrevenue intersegment2024-01-01 → 2024-03-31¥27m
Otherother segmentssegment profit2024-01-01 → 2024-03-31¥36m
Reconciling Itemsreconcilingrevenue2024-01-01 → 2024-03-31−¥32m
Reconciling Itemsreconcilingrevenue intersegment2024-01-01 → 2024-03-31−¥32m
Reconciling Itemsreconcilingsegment profit2024-01-01 → 2024-03-31¥12m
jpcrp040300-q1r_E05155-000Care Welfare IT Systems Businessreportable segmentrevenue2024-01-01 → 2024-03-31¥139m
jpcrp040300-q1r_E05155-000Care Welfare IT Systems Businessreportable segmentrevenue external2024-01-01 → 2024-03-31¥139m
jpcrp040300-q1r_E05155-000Care Welfare IT Systems Businessreportable segmentsegment profit2024-01-01 → 2024-03-31−¥104m
jpcrp040300-q1r_E05155-000Medicine Receipt Computer And Related Businessreportable segmentrevenue2024-01-01 → 2024-03-31¥596m
jpcrp040300-q1r_E05155-000Medicine Receipt Computer And Related Businessreportable segmentrevenue external2024-01-01 → 2024-03-31¥596m
jpcrp040300-q1r_E05155-000Medicine Receipt Computer And Related Businessreportable segmentsegment profit2024-01-01 → 2024-03-31−¥86m
jpcrp040300-q1r_E05155-000Pharmacy Receipt Computer And Related Businessreportable segmentrevenue2024-01-01 → 2024-03-31¥4.6bn
jpcrp040300-q1r_E05155-000Pharmacy Receipt Computer And Related Businessreportable segmentrevenue external2024-01-01 → 2024-03-31¥4.6bn
jpcrp040300-q1r_E05155-000Pharmacy Receipt Computer And Related Businessreportable segmentrevenue intersegment2024-01-01 → 2024-03-31¥4m
jpcrp040300-q1r_E05155-000Pharmacy Receipt Computer And Related Businessreportable segmentsegment profit2024-01-01 → 2024-03-31¥863m
—segment totalrevenue2024-01-01 → 2024-03-31¥5.6bn
—segment totalrevenue external2024-01-01 → 2024-03-31¥5.6bn
—segment totalrevenue intersegment2024-01-01 → 2024-03-31¥32m
—segment totalsegment profit2024-01-01 → 2024-03-31¥708m
Otherother segmentsrevenue2023-01-01 → 2023-03-31¥187m
Otherother segmentsrevenue external2023-01-01 → 2023-03-31¥167m
Otherother segmentsrevenue intersegment2023-01-01 → 2023-03-31¥19m
Otherother segmentssegment profit2023-01-01 → 2023-03-31¥2m
Reconciling Itemsreconcilingrevenue2023-01-01 → 2023-03-31−¥24m
Reconciling Itemsreconcilingrevenue intersegment2023-01-01 → 2023-03-31−¥24m
Reconciling Itemsreconcilingsegment profit2023-01-01 → 2023-03-31¥13m
jpcrp040300-q1r_E05155-000Care Welfare IT Systems Businessreportable segmentrevenue2023-01-01 → 2023-03-31¥140m
jpcrp040300-q1r_E05155-000Care Welfare IT Systems Businessreportable segmentrevenue external2023-01-01 → 2023-03-31¥140m
jpcrp040300-q1r_E05155-000Care Welfare IT Systems Businessreportable segmentsegment profit2023-01-01 → 2023-03-31−¥108m
jpcrp040300-q1r_E05155-000Medicine Receipt Computer And Related Businessreportable segmentrevenue2023-01-01 → 2023-03-31¥791m
jpcrp040300-q1r_E05155-000Medicine Receipt Computer And Related Businessreportable segmentrevenue external2023-01-01 → 2023-03-31¥791m
jpcrp040300-q1r_E05155-000Medicine Receipt Computer And Related Businessreportable segmentsegment profit2023-01-01 → 2023-03-31¥51m
jpcrp040300-q1r_E05155-000Pharmacy Receipt Computer And Related Businessreportable segmentrevenue2023-01-01 → 2023-03-31¥3.8bn
jpcrp040300-q1r_E05155-000Pharmacy Receipt Computer And Related Businessreportable segmentrevenue external2023-01-01 → 2023-03-31¥3.8bn
jpcrp040300-q1r_E05155-000Pharmacy Receipt Computer And Related Businessreportable segmentrevenue intersegment2023-01-01 → 2023-03-31¥5m
jpcrp040300-q1r_E05155-000Pharmacy Receipt Computer And Related Businessreportable segmentsegment profit2023-01-01 → 2023-03-31¥892m
—segment totalrevenue2023-01-01 → 2023-03-31¥4.9bn
—segment totalrevenue external2023-01-01 → 2023-03-31¥4.9bn
—segment totalrevenue intersegment2023-01-01 → 2023-03-31¥24m
—segment totalsegment profit2023-01-01 → 2023-03-31¥838m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 368
ItemContextValueUnit
Year to quarter end consolidated statement of income (text)CurrentYTDDurationText · Plus
Year to quarter end consolidated statement of comprehensive income (text)CurrentYTDDurationText · Plus
Notes changes in scope of consolidation or equity method (text)CurrentYTDDurationText · Plus
Notes changes in accounting policies na quarterly consolidated financial statements (text)CurrentYTDDurationText · Plus
Notes accounting treatments specific to quarterly financial statements quarterly consolidated financial statements (text)CurrentYTDDurationText · Plus
Description of fact that quarterly statement of cash flows has not been prepared (text)CurrentYTDDurationText · Plus
Notes regarding dividend (text)Prior1YTDDurationText · Plus
Notes regarding dividend (text)CurrentYTDDurationText · Plus
Notes segment information etc quarterly consolidated financial statements (text)CurrentYTDDurationText · Plus
Footnotes regarding segment information table (text)Prior1YTDDurationText · Plus
Information about impairment loss of non current assets or goodwill etc for each reportable segment (text)Prior1YTDDurationText · Plus
Footnotes regarding segment information table (text)CurrentYTDDurationText · Plus
Information about impairment loss of non current assets or goodwill etc for each reportable segment (text)CurrentYTDDurationText · Plus
Notes revenue recognition quarterly consolidated financial statements (text)CurrentYTDDurationText · Plus
Notes per share information quarterly consolidated financial statements (text)CurrentYTDDurationText · Plus
Notes significant events after reporting period quarterly consolidated financial statements (text)CurrentYTDDurationText · Plus
Other information consolidated financial statements etc (text)CurrentYTDDurationText · Plus
Information about company which provides guarantee to reporting company (text)FilingDateInstantText · Plus

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2023-12-31pass
balance sheet identityconsolidated 2024-03-31pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-12-31pass
statement vs summary · net assetsconsolidated 2024-03-31pass
statement vs summary · net income attributable to parentconsolidated 2023-01-01/2023-03-31pass
statement vs summary · net income attributable to parentconsolidated 2024-01-01/2024-03-31pass
statement vs summary · revenueconsolidated 2023-01-01/2023-03-31pass
statement vs summary · revenueconsolidated 2024-01-01/2024-03-31pass
statement vs summary · total assetsconsolidated 2023-12-31pass
statement vs summary · total assetsconsolidated 2024-03-31pass